This tender is from the country of Germany in Europe region. The tender was published by Universitätsklinikum Münster on 22 Oct 2024 for Germany Engineering studies IIT study CLEAR Combining Loncastuximab Tesirine and Epcoritamab in RelapsedRefractory Diffuse Large B-cell Lymphoma DLBCL. The last date to submit your bid for this tender was 21 Nov 2024. This tender is for the companies specializing in Engineering studies and similar sectors.
*The deadline for this tender has passed.
Tender Organisation:
Universitätsklinikum Münster
Tender Sector:
Tender Service:
Worldwide
Tender Region:
Tender Country:
Tender CPV:
71335000 : Engineering studies
Tender Document Type:
Tender Notice
Tender Description:
Germany Engineering studies IIT study CLEAR Combining Loncastuximab Tesirine and Epcoritamab in RelapsedRefractory Diffuse Large B-cell Lymphoma DLBCL
Tender Bidding Type:
Tender Notice No:
Tender Document:
Looking for more tenders like this one in Engineering studies? With over 70 million global procurement opportunities and new tenders added daily, Tender Impulse is your gateway to international and local contracting success. Whether you're targeting the Oil and Gas sector in Germany, or expanding across regions, we provide live, accurate, and relevant updates every day.
Our platform sources tenders from:
Every day, we add hundreds of new RFPs, RFQs, EOIs, and contract awards across multiple sectors and geographies. This tender from Germany is just a sample of what's available right now.
Tender Impulse covers:
Each listing is categorized using CPV codes like 71335000, enabling precise filtering. Search by:
While you're viewing a tender in Germany, Tender Impulse offers access to tenders across:
Tender Impulse provides more than listings:
Thousands of new tenders are added daily-across countries, sectors, and CPV codes. With Tender Impulse, you gain strategic insight, timely alerts, and a competitive edge.
Start your free trial to unlock tenders customized to your Oil and Gas, Germany, and Engineering studies categories.